|
|
 Previous Article | Table of Contents | Next Article 
Recognition of minor histocompatibility antigens on lymphocytic and myeloid
leukemic cells by cytotoxic T-cell clones
D van der Harst, E Goulmy, JH Falkenburg, YM Kooij-Winkelaar, SA van Luxemburg- Heijs, HM Goselink and A Brand
Department of Immunohematology and Bloodbank, University Medical Center,
Leiden, The Netherlands.
Clinical studies indicated an enhanced antileukemic effect of allogeneic
bone marrow transplantation (BMT), as compared with autologous BMT. After
allogeneic HLA-identical BMT, donor-derived cytotoxic T lymphocytes (CTLs)
directed at minor histocompatibility (mH) antigens on the recipients,
tissues can be shown. To evaluate the antileukemic reactivity of mH
antigen-specific CTLs, we analyzed the expression of mH antigens on
circulating lymphocytic and myeloid leukemic cells. We show that the
defined mH specificities HA-1 through HA-5 and H-Y are present on leukemic
cells, indicating that mH antigen- specific CTLs are capable of HLA class
I-restricted antigen-specific lysis of leukemic cells. Compared with
interleukin-2-stimulated normal lymphocytes, leukemic cells of lymphocytic
origin are less susceptible to T-cell-mediated cytotoxicity by the HA-2 mH
antigen-specific CTL and the anti-HLA-A2 CTL clone. A possible explanation
for this phenomenon is impaired expression of the LFA-1 adhesion molecule.
Our study suggests that mH antigen-specific HLA class I-restricted CD8+
CTLs may be involved in the graft-versus-leukemia reactivity after
allogeneic BMT.
Volume 83,
Issue 4,
pp. 1060-1066,
02/15/1994
Copyright © 1994 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L. E. M. Oosten, D. Koppers-Lalic, E. Blokland, A. Mulder, M. E. Ressing, T. Mutis, A. G. S. van Halteren, E. J. H. J. Wiertz, and E. Goulmy
TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes
Int. Immunol.,
September 1, 2007;
19(9):
1115 - 1122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. N. Haining, D. S. Neuberg, H. L. Keczkemethy, J. W. Evans, S. Rivoli, R. Gelman, H. M. Rosenblatt, W. T. Shearer, J. Guenaga, D. C. Douek, et al.
Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia
Blood,
September 1, 2005;
106(5):
1749 - 1754.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Schilbach, G. Kerst, S. Walter, M. Eyrich, D. Wernet, R. Handgretinger, W. Xie, H.-G. Rammensee, I. Muller, H.-J. Buhring, et al.
Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction
Blood,
July 1, 2005;
106(1):
144 - 149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zeng, M. W. Graner, S. Thompson, M. Marron, and E. Katsanis
Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells
Blood,
March 1, 2005;
105(5):
2016 - 2022.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. M. Oosten, E. Blokland, A. G. S. van Halteren, J. Curtsinger, M. F. Mescher, J. H. F. Falkenburg, T. Mutis, and E. Goulmy
Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes
Blood,
July 1, 2004;
104(1):
224 - 226.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. E. Heslop, F. K. Stevenson, and J. J. Molldrem
Immunotherapy of Hematologic Malignancy
Hematology,
January 1, 2003;
2003(1):
331 - 349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Billiau, S. Fevery, O. Rutgeerts, W. Landuyt, and M. Waer
Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants
Blood,
August 13, 2002;
100(5):
1894 - 1902.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Klein, M. Wilke, J. Pool, C. Vermeulen, E. Blokland, E. Burghart, S. Krostina, N. Wendler, B. Passlick, G. Riethmueller, et al.
The Hematopoietic System-specific Minor Histocompatibility Antigen HA-1 Shows Aberrant Expression in Epithelial Cancer Cells
J. Exp. Med.,
August 5, 2002;
196(3):
359 - 368.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Mutis, E. Blokland, M. Kester, E. Schrama, and E. Goulmy
Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation
Blood,
June 28, 2002;
100(2):
547 - 552.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. F. Storb, R. Champlin, S. R. Riddell, M. Murata, S. Bryant, and E. H. Warren
Non-Myeloablative Transplants for Malignant Disease
Hematology,
January 1, 2001;
2001(1):
375 - 391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Brenner, C. Rossig, U. Sili, J. W. Young, and E. Goulmy
Transfusion Medicine: New Clinical Applications of Cellular Immunotherapy
Hematology,
January 1, 2000;
2000(1):
356 - 375.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Bonnet, E. H. Warren, P. D. Greenberg, J. E. Dick, and S. R. Riddell
CD8+ minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells
PNAS,
July 20, 1999;
96(15):
8639 - 8644.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. W. Childs, E. Clave, J. Tisdale, M. Plante, N. Hensel, and J. Barrett
Successful Treatment of Metastatic Renal Cell Carcinoma With a Nonmyeloablative Allogeneic Peripheral-Blood Progenitor-Cell Transplant: Evidence for a Graft-Versus-Tumor Effect
J. Clin. Oncol.,
July 1, 1999;
17(7):
2044 - 2044.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Mutis, R. Verdijk, E. Schrama, B. Esendam, A. Brand, and E. Goulmy
Feasibility of Immunotherapy of Relapsed Leukemia With Ex Vivo-Generated Cytotoxic T Lymphocytes Specific for Hematopoietic System-Restricted Minor Histocompatibility Antigens
Blood,
April 1, 1999;
93(7):
2336 - 2341.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Z. Wolpert, P. Grufman, J. K. Sandberg, A. Tegnesjo, and K. Karre
Immunodominance in the CTL Response Against Minor Histocompatibility Antigens: Interference Between Responding T Cells, Rather than with Presentation of Epitopes
J. Immunol.,
November 1, 1998;
161(9):
4499 - 4505.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Mutis, E. Schrama, C. J.M. Melief, and E. Goulmy
CD80-Transfected Acute Myeloid Leukemia Cells Induce Primary Allogeneic T-Cell Responses Directed at Patient Specific Minor Histocompatibility Antigens and Leukemia-Associated Antigens
Blood,
September 1, 1998;
92(5):
1677 - 1684.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Chen, G. S. Chatta, W. D. Rubin, J. G. Clark, R. C. Hackman, D. K. Madtes, D. H. Ligitt, Y. Kusunoki, P. J. Martin, and M. A. Cheever
T Cells Specific for a Polymorphic Segment of CD45 Induce Graft-Versus-Host Disease with Predominant Pulmonary Vasculitis
J. Immunol.,
July 15, 1998;
161(2):
909 - 918.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ostankovitch, A. Buzyn, D. Bonhomme, F. Connan, D. Bouscary, F. Heshmati, F. Dreyfus, J. Choppin, and J.-G. Guillet
Antileukemic HLA-Restricted T-Cell Clones Generated With Naturally Processed Peptides Eluted From Acute Myeloblastic Leukemia Blasts
Blood,
July 1, 1998;
92(1):
19 - 24.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. H. Warren, P. D. Greenberg, and S. R. Riddell
Cytotoxic T-Lymphocyte-Defined Human Minor Histocompatibility Antigens With a Restricted Tissue Distribution
Blood,
March 15, 1998;
91(6):
2197 - 2207.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. den Haan, L. M. Meadows, W. Wang, J. Pool, E. Blokland, T. L. Bishop, C. Reinhardus, J. Shabanowitz, R. Offringa, D. F. Hunt, et al.
The Minor Histocompatibility Antigen HA-1: A Diallelic Gene with a Single Amino Acid Polymorphism
Science,
February 13, 1998;
279(5353):
1054 - 1057.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A.J. Barrett
Mechanisms of the Graft-versus-Leukemia Reaction
Stem Cells,
July 1, 1997;
15(4):
248 - 258.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
E. Behar, N. J. Chao, D. D. Hiraki, S. Krishnaswamy, B. W. Brown, J. L. Zehnder, and F. C. Grumet
Polymorphism of Adhesion Molecule CD31 and Its Role in Acute Graft-Versus-Host Disease
N. Engl. J. Med.,
February 1, 1996;
334(5):
286 - 291.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W Wang, L. Meadows, J. den Haan, N. Sherman, Y Chen, E Blokland, J Shabanowitz, A. Agulnik, R. Hendrickson, C. Bishop, et al.
Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein
Science,
September 15, 1995;
269(5230):
1588 - 1590.
[Abstract]
[PDF]
|
|
|
|
|
